Internal Medicine/Hematology/Oncology


Uzair B. Chaudhary, MD

Professor of Clinical Medicine, UCSF
Chief, Hematology/Oncology


  Medical School: The Aga Khan University Medical College, Pakistan
  Internship: The Aga Khan University Medical College, Pakistan
  Externship: Indiana University Hospitals, St. Louis, MO
  Residency: Indiana University Hospitals, St. Louis, MO
  Fellowship Hematology & Oncology, University of California, San Francisco Hospitals, SF, CA
  Board Certified:

American Board of Internal Medicine, Diplomate

American Board of Internal Medicine, Medical Oncology

American Board of Internal Medicine, Hematology           

  Awards and Recognition:
  1. Board of Secondary Education Merit Scholarship
  2. Berlex Oncology Foundation Award
  3. AMGEN Fellow of the Year Award
  4. Rhone-Poulenc Rorer Oncology Annual Fellowship Award
  5. SmithKline Beecham National Oncology Fellow’s Forum
  6. ASCO Travel Award
  7. Nominated for Michael E. Assey Teaching Award
  8. Nominated for Health Sciences Foundation Developing Scholars Award (MUSC)
  9. Finalist for the Faculty Excellence Award
  10. Nominated for Monthly Magnet MD Award


  Publications (since 2009):

Toxicity and survival outcomes of Re-irradiation with Hyperfractionated split-course radiotherapy and concurrent chemotherapy for loco-regionally recurrent, previously irradiated head and neck cancers. John M. Watkins, Keisuke S. Shirai, Amy Herrin Paul E. O Brien, Robert K. Stuart, Uzair B. Chaudhary, Elizabeth Garrett-Mayer,Terry A. Day, M. Boyd Gillespie and Anand K. Sharma. Head Neck. 2009 Apr;31(4):493-502

Dramatic PSA response with activated hemicellulose compound (AHCC)in metastatic castrate-resistant prostate cancer (CRPC). Turner J and Uzair B. Chaudhary. Anticancer Drugs. 2009 Mar;20(3):215-6 

Restaging and assessment of respectability of locally advanced pancreatic cancer by EUS after neo-adjuvant therapy. J Walker, U Chaudhary, N Esanola, J Romagnuola, R Hawes, B Hoffman. Gastrointestinal Endoscopy, Vol. 69, no 2, pp S266-S266, 2009

Primary testicular lymphoma and AIDS. Verma N, Chaudhary UB, Costa LJ, Gudena V, Lazarchick J. Ann Clin Lab Sci. 2010. 40(1):75-9.

Finasteride. Turner J and Uzair B. Chaudhary. Expert Opinion on Drug Metabolism and Toxicology.


Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum Cā‚ā‚ˆ-ceramide as a novel biomarker for monitoring response. Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA, Gillespie MB, Sharma AK, Wilhoit CS, Bostick R, Senkal CE, Hannun YA, Bielawski J, Simon GR, Shirai K, Ogretmen B. Clin Cancer Res. 2011 Sep 15;17(18):6097-105. Epub 2011 Jul 26

Phase II study of Gemcitabine and Irinotecan for metastatic Bladder Cancer. Uzair B. Chaudhary, Vinay Gudena, Harry Clarke, Stephen Savage, Nancy Curry, Amy Wshlquist and Thomas Keane. AM J Clinic Oncol. 2012 Dec 13 [Epub ahead of print]

Neurologic Manifestation of Colonic Adenocarcinoma. Terence T. Sio, Mersedes PAredes, Uzair Chaudhary. Rare Tumors 2012: Volume 4:e32

Durable complete remission with Bevacizumab-based chemotherapy in a patient with metastatic Gastroesophageal Junction Cancer. Mohammad H. Rashid, Mersiha Hadziahmetovic and Uzair B. Chaudhary. [Gastroinestinal Cancer Research. 2012 Sep; 5(5): 177-8

Phase I trial of weekly docetaxel, total androgen blockade, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinoma. Marshall DT, Ramey S, Golshayan AR, E Keane T, Kraft AS, Chaudhary U. Clin Genitourin Cancer. 2014 Apr;12(2):80-6. doi: 10.1016/j.clgc.2013.11.019. Epub 2013 Nov 13. PMID: 24378335

Chemotherapeutic and Targeted Biological Agents for Metastatic Bladder Cancer: A comprehensive Review. Terrence Sio, Jocelyn Ko, Vinay Gudena, Nitin Verma, Uzair Chaudhary. (IJU-01191-2013. RI){Accepted for publication in International Journal of Urology}

Phase II Trial of Induction Gemcitabine, Oxaliplatin and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients with Nonmetastatic, Locally Advanced Pancreatic Cancer. NF Esnaola, UB Chaudhary, P O'Brien, E Garrett-Mayer, ER Camp, MB Thomas, DJ Cole, AJ Montero, BJ Hoffman, J Ramognuolo, Kelly Orwat, DT Marshall. The International Journal of Radiation Oncology, Biology & Physics Volume 88, Number 4, Pages 837-844. 

Neo-adjuvant therapies for unresectable liver metastases.Matthew Beldner, Uzair B. Chaudhary and Mohammad W. Saif. (Submitted)

The emerging role of targeted therapies in metastatic renal cell carcinoma (Invited commentary for Biochemical Pharmacology). Uzair B. Chaudhary. (In Preparation)

M-TOR inhibition for cancer (Invited commentary for Current cancer drug targets). Uzair B. Chaudhary. (In Preparation)


Book and Chapters:

Submitted Manuscript - Neo-adjuvant therapies for unresectable liver metastases.Matthew Beldner, Uzair B. Chaudhary and Mohammad W. Saif. (Submitted)

The emerging role of targeted therapies in metastatic renal cell carcinoma (Invited commentary for Biochemical Pharmacology). Uzair B. Chaudhary - Manuscripts in Preparation

M-TOR inhibition for cancer (Invited commentary for Current cancer drug targets). Uzair B. Chaudhary. - Manuscript in Preparation


Non-platinum chemotherapy for metastatic bladder cancer. Vinay Gudena, Nitin Verma and Uzair B. Chaudhary. - Manuscript in Preparation




Intermittent Androgen Deprivation (IAD) as treatment for localized and recurrent prostate cancer. Uzair B. Chaudhary, Gary D. Grossfeld, David M. Reese, Eric J. Small, and Peter R. Carroll

Intermittent Androgen Deprivation (IAD); Patterns of failure in clinically localized prostate cancer. Uzair B. Chaudhary, Gary D., David M. Reese, Eric J. Small, and Peter R. Carroll (Poster presenation at the 36th American Society of Clinical Oncology Meeting)

Long term complications of chemotherapy for germ cell tumours. U.B. Chaudhary and J.R. Haldas. Urological Surveys. The Journal of Urology: 172 (3) page1204. Editorial comment by Dr Jerome P. Richie, M.D.

Phase II trial of pegylated Interferon alpha-2b, GM-CSF, and Thalidomide in metastaticprogressive renal cell carcinoma. Am Soc Clin Oncol. (Abstract #4800) R. Sawhney, F. Brescia, T.Keane, H.Clark, U.B. Chaudhary.

Concurrent split course hyperfractionated radiotherapy (HfxRT) with biweekly cisplatin (DDP) and paclitaxel (P) with recurrent irradiated squamous cell carcinoma of the head and neck (SCCHN): The MUSC experience. R. Sawhney, A. Dragun, R.K. Stuart, U.B. Chaudhary, T.Day, M.B. Gillespie, A. Sharma.

Phase I trial of bortezomib and celecoxib in patients with advanced solid tumors S. Dunder, U. Chaudhary, M. Green, M. Meyer, F. Brescia, A. Kraft, A. Montero, S. Salzer.

Detection of circulating tumor cells in the peripheral blood of patients with Androgen-independent, Advanced or Metastatic Prostate cancer. D.T. Marshall, M.C. Mitas, U.B. Chaudhary, S. Gattoni-Celli. (Submitted to ASTRO)

Preliminary results of a phase II study of Induction Gemcitabine/Oxalipatin (GEMOX) and Cetuximab followed by surgery or concurrent Instensity Modulated Radiation Therapy (IMRT) and Capecitabine for locally advanced Pancreatic Cancer. J Brashears, AJ Brisendine, U.B Chaudhary, NF Esanola, AJ Montero and TD Marshall.(Poster presentation at ASTRO)

Phase II trial with Doxotubicin and Gemcitabine comination for the treatment of head and neck cancers: From the Sphingolipid-Signaling bench to the bedside. Uzair Chaudhary, Paul O'Brien, Larry Afrin, Keisuke Shirai, Terry A Day, Boyd Gillispie, Joshua Horning, Anand Sharma, Christina Wihoit, Sahar Saddoughi, Can E Senkal, Yusuf A. Hannun and Besim Ogretmen. (Poster presentation at the Hollings Cancer Center Retreat)

Results of a Phase II neoadjuvant tial with gemcitabine/oxaliplatin and cetuximab followed by surgery or concurrent intensity modulated radiation therapy (IMRT) with capecitabine for patients with borderline resectable and unresectable nonmetastatic pancreatic cancer. U.B. Chaudary, V. Gudina, S. Cole, P. O'Brien, A.J. Montero, D.T. Marshall, W. Amy, B. Hoffman. (Poster presentation at ASCO GI 2009)

Hepatocellular Cancer Presentation as an Intra-Cardiac Mass. Uzair B. Chaudary, Ambar Rahman, Aifra Ahmend, Pervaiz Chaudhary.(Poster persentation at the ACP 2009 Annual meeting)

Rapidly Progressive Renal Failure Presentation as Multiple Myeoma. Uzair B. Chaudhary, Ambar Rahman, Alfra Ahmed.(Poster presentation at the ACP Annual meeting)

IMRT To Reduce Toxicity In Chemoradiation For Locally Advanced Pancreatic Cancer - Preliminary Results Of A Phase II Trial. U. Chaudhary 1,2, D. T. Marshall1, P. O'Brien1, B. Hoffman1, E. Garrett-Mayer1, A. Brisendine1, B. D. Jones1, L. E. Terwilliger1, K. Cranford1, N. Esnaola